Call Us: 1.800.873.5297

By

FDA Warns of Rare, But Potentially Fatal, Skin Reactions with Ziprasidone

On December 11, 2014, the Food and Drug Administration (FDA) issued a Drug Safety Communication warning that the antipsychotic drug Ziprasidone (brand name, Geodon), which is used to treat schizophrenia and bipolar disorder, is associated with rare, but potentially fatal, serious skin reactions that can affect other parts of the body. The FDA reports that […]

By

JPML Decides to Centralize Cases Involving Syngenta Corporation in Kansas (MDL 2591)

Law360 reports that the Judicial Panel on Multidistrict Litigation (JPML) has agreed to centralize 177 lawsuits filed against Syngenta Corporation in the District of Kansas (In re: Syngenta AG MIR162 Corn Litigation, MDL 2591). The JPML said that it chose the District of Kansas because it is “readily accessible”, and assigned the MDL to Judge […]

By

Judge Says Transvaginal Mesh Manufacturer C.R. Bard Faces Billions in Verdicts, Bloomberg Reports

Bloomberg reports that Judge Joseph Goodwin, the federal judge overseeing the C.R. Bard Multidistrict Litigation (MDL 2187) in West Virginia, “took the unusual step of urging C.R. Bard to settle thousands of lawsuits over defective vaginal-mesh implants because juries may award billions of dollars in damages.” Judge Goodwin said during a December 9th hearing, “I […]

By

Xarelto® Lawsuit (MDL 2592) Update: JPML Centralizes MDL in Louisiana

On October 9, 2014, and on behalf of six plaintiffs, Roger Denton of Schlichter, Bogard & Denton, LLP filed a petition with the Judicial Panel on Multidistrict Litigation (JPML) requesting that all federally-filed Xarelto® cases be consolidated for coordinated pretrial proceedings. On December 4, 2014, a hearing before five federal judges on the Multidistrict Litigation […]

By

Transvaginal Mesh (MDL 2326) Update: Cases Against Boston Scientific Move Forward After First Two Bellwether Trials

Cases against Boston Scientific continue to move forward in the Multidistrict Litigation (In re: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation, MDL 2326) before The Honorable Judge Joseph R. Goodwin in the United States District Court for the Southern District of West Virginia. According to the Court’s most recent Pretrial Order, new deadlines […]

By

Takata Has Struggled to Tame Airbag Compound for Decades, The New York Time Reports

The New York Times reports that Takata has struggled for nearly two decades to tame an unstable compound that is thought to be the source of airbag ruptures. According to The New York Times, “[a]s far back as June 1995, a patent application filed by Takata expressed concern over using the compound, saying that it […]

By

Gynecologists Continue Using Power Morcellators Despite FDA Warning, The Wall Street Journal Reports

The Wall Street Journal reports that doctors nationwide are continuing to use a popular surgical tool, known as power morcellators, even after the United States Food and Drug Administration (FDA) warned that the device can spread undetected cancer. The Wall Street Journal notes that this demonstrates “the limits of the regulator’s reach into clinical practice.” In […]

By

Financial Ties Between FDA Advisory Committee Members and Companies Not Always Disclosed, The Wall Street Journal Reports

An analysis by The Wall Street Journal shows that the United States Food and Drug Administration (FDA) does not always disclose financial ties between members of its medical device advisory committee and the companies that manufacturer medical devices. In particular, the WSJ analysis found that “a third of advisers on the FDA’s cardiology, orthopedics and […]

By

FDA Issues Safety Announcement regarding Risks of Long-Term Antiplatelet Therapy

The FDA has issued a Safety Announcement regarding the safety information and preliminary data from the Dual Antiplatelet Therapy (DAPT) trial, which was published in the New England Journal of Medicine on November 16, 2014. The FDA stated that it is “evaluating preliminary data from a clinical trial showing that treatment for 30 months with […]

By

TVM Lawsuit Update (MDL 2326): Boston Scientific Ordered by Jury to Pay $18.5 Million in Second Federal Trial

For the second time this month, Boston Scientific has been found liable by a jury in federal court for selling defective vaginal mesh implants, according to the Chicago Tribune. A jury in West Virginia federal court deliberated for six hours before concluding that Boston Scientific failed to adequately warn the four women at issue and […]

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.